OxyContin (oxycodone hydrochloride controlled release) is a long-acting preparation of oxycodone that is used as an opioid analgesic to treat chronic pain conditions. We report a patient who ingested a massive quantity of OxyContin and had altered mental status, noncardiogenic pulmonary edema, and hypoventilation that proved refractory to naloxone administration. She required mechanical ventilation for 3 days before recovering completely. The severity and length of poisoning was likely related both to the quantity and formulation of the oxycodone ingested.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1067/mem.2002.128143 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Refractory pruritus caused by sintilimab and its clinical management: A case report.
Heliyon
July 2024
Department of Pharmacy, Clinical Medical College and the First Affiliated Hospital of Chengdu Medical College, 278 Baoguang Street, Xindu District Chengdu, 610500, Sichuan, China.
Article Synopsis
- Immune checkpoint inhibitors (ICIs) can lead to immune-related adverse events (irAEs), with skin reactions like rash and pruritus being the most common, affecting patients' quality of life.
- Pruritus often co-exists with other skin issues, and while it’s usually mild, it can become severe and resistant to traditional treatments, posing serious risks.
- The case of a patient with gallbladder neuroendocrine carcinoma shows that naloxone can effectively relieve refractory pruritus after conventional therapies fail, highlighting the role of clinical pharmacists in creating personalized treatment plans.
A novel tramadol-polycaprolactone implant could palliate heroin conditioned place preference and withdrawal in rats: behavioral and neurochemical study.
Behav Pharmacol
August 2024
Refractories, Ceramics and Building Materials Department, Advanced Materials, Technology and Mineral Resources Research Institute, National Research Centre (NRC), Giza, Egypt.
Drug dependence is a chronic brain disease characterized by craving and recurrent episodes of relapse. Tramadol HCl is a promising agent for withdrawal symptoms management, considering its relatively low abuse potential and safety. Oral administration, however, is not preferred in abstinence maintenance programs.
View Article and Find Full Text PDFQuadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report.
Subst Abuse Treat Prev Policy
February 2024
Denver Health & Hospital Authority, 777 Bannock St, 80204, Denver, CO, USA.
Background: Combinations of alcohol use disorder (AUD) medications have been investigated, but few if any reports describe patients maintained on more than two options at the same time.
Case Presentation: We report a case of a middle-aged man hospitalized with gastrointestinal bleeding and acute kidney injury who had been maintained on four AUD medications (naltrexone, acamprosate, disulfiram, and gabapentin) and multiple psychiatric medications simultaneously as an outpatient. Direct quotations of his experiences with each AUD medication are included, revealing some deviations from what was prescribed as well as nuanced perceptions of effects.
Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics.
Fundam Clin Pharmacol
June 2024
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Background/objectives: Clinical responses to naldemedine vary between individuals with advanced cancer. This is a prospective, single-center, observational study aimed to evaluate the influence of genetic polymorphisms and cachexia status on plasma naldemedine and clinical responses.
Methods: Forty-eight patients being treated with naldemedine for opioid-induced constipation under treatment of cancer pain were enrolled.
Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management.
Int J Pharm Compd
December 2023
Professional Compounding Centers of America, Houston, Texas.
Naltrexone is a competitive opioid receptor antagonist indicated to treat opioid and alcohol dependence. In the U.S.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!